Moexipril Hydrochloride
- Product NDC
- 0093-5150
- 11-digit product format
- 000935150
- Labeler code
- 0093
- Product ID
- 0093-5150_2c29e2eb-8956-4fb2-a371-57466c82f348
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Moexipril Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA076204
- Marketing category
- ANDA
- Marketing start
- 2003-05-08
- Substance
- MOEXIPRIL HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Moexipril Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MOEXIPRIL HYDROCHLORIDE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Q1UMG3UH45 |
| Rxcui | 1299896, 1299897 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-5150-01 | Moexipril Hydrochloride | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 11 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| MOEXIPRIL HYDROCHLORIDE | ACTIVE INGREDIENT | Q1UMG3UH45 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| MOEXIPRILAT | ACTIVE MOIETY | H3753190JS | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| HYPROMELLOSE 2910 (15 MPA.S) | INACTIVE INGREDIENT | 36SFW2JZ0W | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| SODIUM BICARBONATE | INACTIVE INGREDIENT | 8MDF5V39QO | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| MOEXIPRIL HYDROCHLORIDE | ACTIVE INGREDIENT | Q1UMG3UH45 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| MOEXIPRILAT | ACTIVE MOIETY | H3753190JS | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSE 2910 (15 MPA.S) | INACTIVE INGREDIENT | 36SFW2JZ0W | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| SODIUM BICARBONATE | INACTIVE INGREDIENT | 8MDF5V39QO | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-5150 | MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.] | 10 | Current NDC, Legacy NDC, 1 package rows | 20200829_5d4078f3-b621-475f-a4e6-005de2e62b32.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-5150-01 | 00093515001 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-5150-01) | 2003-05-08 | 0000-00-00 | No | No | Current |